Literature DB >> 9761518

Automated peritoneal dialysis: a Spanish multicentre study.

A M Rodríguez1, N V Díaz, L P Cubillo, J T Plana, M A Riscos, R M Delgado, C M Herrera, E A Ribes, F T Molina, M M Heras, A T González, C G Cantón, A R Fernández, E B Laborda, M N Zurita, F F Girón, P S Santana.   

Abstract

BACKGROUND: A prospective sequential study on continuous ambulatory peritoneal dialysis (CAPD) and three techniques of automated peritoneal dialysis (APD) was conducted to assess peritoneal clearances, the influence of peritoneal permeability on nocturnal APD clearances and the suitability of the peritoneal equilibration test (PET) for predicting clearances on APD.
METHODS: After performing a PET, a series of clinical, biochemical and dialysis adequacy markers were evaluated after 2 months on CAPD, continuous cycling peritoneal dialysis (CCPD) and tidal volume peritoneal dialysis (TPD) with 50% and 25% tidal volumes. Forty five patients participated and 33 completed the study.
RESULTS: Serum urea and creatinine decreased significantly whereas haemoglobin and glucose increased. Mean peritoneal urea clearance (1/week) was 55.40+/-8.76 on CAPD, 74.82+/-12.62 on CCPD, 69.20+/-14.63 on TPD (tidal 50%) and 66.89+/-13.23 on TPD (tidal 25%); mean creatinine clearance (1/week/1.73 m2) was 42.80 +/- 9.95, 52.19 +/- 11.11, 51.31 +/- 13.3 and 49.17 +/- 11.83, respectively. Both clearances were significantly lower on CAPD than on APD (P<0.001). CCPD was the automated technique that provided the best nocturnal urea clearance (P<0.01). Nocturnal creatinine clearance did not show significant differences between CCPD and TPD (tidal 50%), being better with both techniques than with TPD (tidal 25%). There were statistically significant differences between nocturnal dialysate to plasma (D/P) ratios and those corresponding to the nearest times in the PET. The urea D/P ratio at 180 min and the creatinine D/P ratio at 240 min of the PET were the parameters that better estimated nocturnal clearances on APD.
CONCLUSIONS: This study confirms that TPD does not improve the results of CCPD. Significant differences between D/P ratios during actual nocturnal cycles and PETs were observed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9761518     DOI: 10.1093/ndt/13.9.2335

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

1.  Comparison of Blood Pressure Control and Left Ventricular Hypertrophy in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD).

Authors:  Jong Soon Jang; Soon Kil Kwon; Hye-Young Kim
Journal:  Electrolyte Blood Press       Date:  2011-06-30

Review 2.  Can peritoneal dialysis be used as a long term therapy for end stage renal disease?

Authors:  Michele Giannattasio; Michele Buemi; Flavia Caputo; Giusto Viglino; Enrico Verrina
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

Review 3.  Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis for end-stage renal disease.

Authors:  K S Rabindranath; J Adams; T Z Ali; A M MacLeod; L Vale; J Cody; S A Wallace; C Daly
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18

4.  Strategies for preserving residual renal function in peritoneal dialysis patients.

Authors:  Arkom Nongnuch; Montira Assanatham; Kwanpeemai Panorchan; Andrew Davenport
Journal:  Clin Kidney J       Date:  2015-01-13

5.  Evaluation of a system for sorbent-assisted peritoneal dialysis in a uremic pig model.

Authors:  Maaike K van Gelder; Joost C de Vries; Frank Simonis; Anneke S Monninkhof; Diënty H M Hazenbrink; Giulia Ligabue; Silvia Giovanella; Jaap A Joles; Marianne C Verhaar; Maria A Bajo Rubio; Rafael Selgas; Gianni Cappelli; Karin G F Gerritsen
Journal:  Physiol Rep       Date:  2020-12

6.  A 2-year follow-up study of patients on automated peritoneal dialysis.

Authors:  C Shyam Sunder Rao; P Charan; G Diwaker Naidu; G Swarnalatha; R Ram; K V Dakshinamurty
Journal:  Indian J Nephrol       Date:  2013-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.